Presbyopia Market to Exhibit Moderate Growth Rate till 2030, Estimates DelveInsight | Key Companies – Allergan, Novartis, Eyenovia, AbbVie, Regeneron, Amgen, Ocuphire Pharma and Others

October 06 19:28 2021
Presbyopia Market to Exhibit Moderate Growth Rate till 2030, Estimates DelveInsight | Key Companies - Allergan, Novartis, Eyenovia, AbbVie, Regeneron, Amgen, Ocuphire Pharma and Others
Delveinsight Business Research LLP

DelveInsight’s “Presbyopia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Presbyopia Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Presbyopia market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Presbyopia Market

Presbyopia: An Overview

Presbyopia is defined as the gradual loss of near-focusing ability that occurs with age. This typically comes on between the ages of 40 and 60 as the lenses of the eyes naturally lose elasticity due to the aging process. A variety of options are available for optical correction of presbyopia, and the optometrist makes recommendations based on the patient’s specific vocational and avocational needs. 

Several types of surgery are available and new techniques and technologies are making them safer and more effective. Refractive surgical procedures include Conductive Keratoplasty, LASIK, LASEK, and Photorefractive Keratectomy. Current clinical management of presbyopia also includes off-label treatment such as nonsteroidal anti-inflammatory drugs (NSAIDs), parasympathetic agonists, miotic agents, or some other tempering agents. 

Presbyopia Market Key Facts

  • Among the 7MM, the highest number of prevalent cases of Presbyopia were recorded in the United States with 117,369,699 cases in the year 2020.

  • In the year 2020, the total prevalent cases of Presbyopia were 134,726,460 in EU-5 which are expected to grow during the forecast period, i.e., 2021–2030.

  • As per DelveInsight’s analysis, in 2020 Japan accounts for 11,981,628 and 17,972,442 male and female cases respectively for Presbyopia. 

  • As per the study Bourne et al. (2018), the crude prevalence of presbyopia was 18.94% in 2015, and women were more likely to be blind or MSVI than men.

  • According to DelveInsight’s analysis, females are affected more as compared to males, in case of Presbyopia.  

Get FREE sample copy at:

Key Benefits of Presbyopia Market Report

  • The report provides an in-depth analysis of Presbyopia Market Size and Share till 2030 in the seven major markets.

  • The report will help in developing business strategies by understanding the Presbyopia Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.

  • It covers Presbyopia current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.

  • The report provides a detailed assessment of the Presbyopia market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Presbyopia Market 

The Presbyopia Market Size is anticipated to increase owing to the rise in the number of Prevalent cases of Presbyopia during the forecast period in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Presbyopia market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Presbyopia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Presbyopia Epidemiology

The epidemiology section covers insights about the historical and current Presbyopia patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Presbyopia Epidemiology Segmentation

  • Total Diagnosed Cases of Presbyopia

  • Total Prevalent Cases of Presbyopia

  • Gender-specific Cases of Presbyopia

  • Total Age-specific Cases of Presbyopia

  • Total Treated cases of Presbyopia

Presbyopia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Presbyopia market or expected to get launched in the market during the study period. The analysis covers Presbyopia market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Presbyopia Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

The dynamics of the Presbyopia market is anticipated to change in the coming years owing to the emerging pipeline therapies, the rise in the number of healthcare spending, and the increasing awareness across the world.

Some of the key Companies in the Presbyopia market include:

  • Allergan 

  • Novartis

  • Eyenovia

  • AbbVie

  • Regeneron 

  • Amgen

  • Ocuphire Pharma

And many others.

Presbyopia Drugs Covered in the Report Include:

  • AGN-190584

  • MicroLine (Pilocarpine Ophthalmic)

  • PresbiDrops (CSF-1)

  • UNR844 (Lipoic acid cholineester)

  • Nyxol (Phentolamine Mesylate)

  • VTI-001 (Brimochol)

  • AGN-241622

And many more.

Request for Sample @ Presbyopia Therapeutics Market Assessment

Table of Content

1. Key Insights

2. Executive Summary 

3. Presbyopia Competitive Intelligence Analysis

4. Presbyopia Market Overview at a Glance

5. Presbyopia Disease Background and Overview

6. Presbyopia Patient Journey

7. Presbyopia Epidemiology and Patient Population

8. Presbyopia Treatment Algorithm, Current Treatment, and Medical Practices

9. Presbyopia Unmet Needs

10. Key Endpoints of Presbyopia Treatment

11. Presbyopia Marketed Products

12. Presbyopia Emerging Therapies

13. Presbyopia Seven Major Market Analysis

14. Attribute Analysis

15. Presbyopia Market Outlook (7 major markets)

16. Presbyopia Access and Reimbursement Overview

17. KOL Views on the Presbyopia Market.

18. Presbyopia Market Drivers

19. Presbyopia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Trending Healthcare Blogs By DelveInsight

IgA Nephropathy Market Size and Share Analysis

IgA Nephropathy market is expected to transform in the coming years with the launch of novel therapeutic assets. The IgA Nephropathy market size is also anticipated to grow in the next decade that was estimated to be USD 109.3 million in 2020 in the 7MM. Leading pharma companies such as Calliditas Therapeutics AB, Chinook Therapeutics, Inc., Novartis, Omeros Corporation, among others are enthusiastically working at the therapeutics front to transform the market outlook with a standard and curative approach. For more details, visit: IgA Nephropathy Market

Myocardial Infarction Market Outlook

As per DelveInsight, in 2020, the estimated Myocardial Infarction Market size was found to be USD 11,038 million in the 7MM (i.e. the USA, EU5, and Japan). Some of the prominent players in the Myocardial Infarction Market include CSL Behring, Idorsia Pharmaceuticals, TRPHARM, Faraday Pharmaceuticals, Athera Biotechnologies, BioCardia, Beijing Northland Biotech, Olatec Therapeutics, among several others. Read More: Myocardial Infarction Market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States